Nomura Holdings Inc Abbott Laboratories Transaction History

Nomura Holdings Inc

$41.1 Billion
Q3 2024

A detailed history of Nomura Holdings Inc transactions in Abbott Laboratories stock. As of the latest transaction made, Nomura Holdings Inc holds 36,462 shares of ABT stock, worth $4.19 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

36,462

Previous 132,670 72.52%

Holding current value

$4.19 Million

Previous $13.8 Million 69.84%

% of portfolio

0.01%

Previous 0.03%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$100.07 - $118.13 $9.63 Million - $11.4 Million	-96,208 Reduced 72.52%	36,462 $4.16 Million
Q2 2024 Aug 14, 2024	BUY	$100.73 - $112.44 $12 Million - $13.4 Million	118,810 Added 857.22%	132,670 $13.8 Million
Q1 2024 May 15, 2024	BUY	$109.52 - $120.96 $1.52 Million - $1.68 Million	13,860 New	13,860 $1.58 Million
Q4 2023 Feb 14, 2024	BUY	$90.19 - $110.4 $3.16 Million - $3.86 Million	34,986 New	34,986 $3.85 Million
Q2 2023 Aug 14, 2023	BUY	$100.78 - $112.29 $2.32 Million - $2.58 Million	22,993 New	22,993 $2.51 Million
Q3 2022 Nov 15, 2022	BUY	$96.76 - $112.03 $11.5 Million - $13.3 Million	118,934 Added 822.96%	133,386 $13.3 Million
Q2 2022 Aug 15, 2022	SELL	$102.07 - $123.37 $8.83 Million - $10.7 Million	-86,497 Reduced 85.68%	14,452 $1.61 Million
Q1 2022 May 18, 2022	SELL	$114.02 - $139.04 $3.47 Million - $4.23 Million	-30,445 Reduced 23.17%	100,949 $12 Million
Q4 2021 Feb 14, 2022	SELL	$115.53 - $141.46 $674,002 - $825,277	-5,834 Reduced 4.25%	131,394 $18.1 Million
Q3 2021 Nov 15, 2021	BUY	$116.66 - $129.06 $11.3 Million - $12.5 Million	96,771 Added 239.19%	137,228 $16.1 Million
Q2 2021 Aug 16, 2021	BUY	$105.79 - $124.53 $3.73 Million - $4.39 Million	35,269 Added 679.82%	40,457 $4.65 Million
Q1 2021 May 17, 2021	SELL	$108.84 - $128.23 $21.4 Million - $25.3 Million	-196,981 Reduced 97.43%	5,188 $624,000
Q4 2020 Feb 16, 2021	BUY	$105.0 - $114.42 $14.6 Million - $15.9 Million	138,635 Added 218.21%	202,169 $21.9 Million
Q3 2020 Nov 12, 2020	SELL	$91.64 - $111.29 $90,723 - $110,177	-990 Reduced 1.53%	63,534 $6.86 Million
Q2 2020 Aug 14, 2020	BUY	$76.57 - $98.0 $4.94 Million - $6.32 Million	64,524 New	64,524 $5.89 Million
Q1 2020 May 14, 2020	SELL	$62.82 - $91.86 $1.3 Million - $1.9 Million	-20,650 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$78.51 - $87.4 $478,832 - $533,052	6,099 Added 41.91%	20,650 $1.78 Million
Q3 2019 Nov 14, 2019	SELL	$81.84 - $88.74 $220,968 - $239,598	-2,700 Reduced 15.65%	14,551 $1.2 Million
Q2 2019 Aug 14, 2019	SELL	$72.88 - $85.0 $41,177 - $48,025	-565 Reduced 3.17%	17,251 $1.44 Million
Q1 2019 May 14, 2019	SELL	$66.22 - $80.06 $624,123 - $754,565	-9,425 Reduced 34.6%	17,816 $1.4 Million
Q4 2018 Feb 14, 2019	BUY	$65.56 - $74.27 $370,020 - $419,179	5,644 Added 26.13%	27,241 $1.97 Million
Q3 2018 Nov 14, 2018	SELL	$60.81 - $73.36 $2.06 Million - $2.48 Million	-33,868 Reduced 61.06%	21,597 $1.53 Million
Q2 2018 Aug 14, 2018	SELL	$57.57 - $63.54 $7.13 Million - $7.86 Million	-123,774 Reduced 69.06%	55,465 $2.37 Million
Q1 2018 May 14, 2018	SELL	$56.27 - $63.62 $22.6 Million - $25.5 Million	-401,512 Reduced 69.14%	179,239 $10.5 Million
Q1 2018 May 14, 2018	BUY	$56.27 - $63.62 $10.1 Million - $11.4 Million	179,239 Added 44.64%	580,751 $32.9 Million
Q4 2017 Feb 14, 2018	BUY	$53.68 - $57.47 $7.21 Million - $7.72 Million	134,359 Added 50.29%	401,512 $22.4 Million
Q3 2017 Nov 14, 2017	BUY	$48.06 - $53.64 $12.8 Million - $14.3 Million	267,153	267,153 $14.1 Million

Others Institutions Holding ABT

# of Institutions

3,185

Shares Held

1.31B

Call Options Held

8.74M

Put Options Held

7.89M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $201B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nomura Holdings Inc, based on Form 13F filings with the SEC.

News

Stay updated on Nomura Holdings Inc with notifications on news.

Account

Nomura Holdings Inc Abbott Laboratories Transaction History